{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:41:46Z","timestamp":1792172506435,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03826-x","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T06:45:03Z","timestamp":1744267503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparative effects of aerobic and resistance exercise on bile acid profiles and liver function in patients with non-alcoholic fatty liver disease"],"prefix":"10.1186","volume":"25","author":[{"given":"Jiasen","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenle","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"3826_CR1","doi-asserted-by":"publisher","first-page":"1199429","DOI":"10.3389\/fendo.2023.1199429","volume":"14","author":"X Xu","year":"2023","unstructured":"Xu X, Xu H, Liu X, et al. MBOAT7 rs641738 (C>T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese population. Front Endocrinol (Lausanne). 2023;14:1199429.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"3826_CR2","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","volume":"69","author":"Z Younossi","year":"2019","unstructured":"Younossi Z, Tacke F, Arrese M, et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2019;69(6):2672\u201382.","journal-title":"Hepatology"},{"issue":"1","key":"3826_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology."},{"issue":"4","key":"3826_CR4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.cld.2009.07.007","volume":"13","author":"JM Page","year":"2009","unstructured":"Page JM, Harrison SA. NASH and HCC. Clin Liver Dis. 2009;13(4):631\u201347.","journal-title":"Clin Liver Dis"},{"issue":"10290","key":"3826_CR5","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet"},{"issue":"6","key":"3826_CR6","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H, et al. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66(6):1138\u201353.","journal-title":"Gut"},{"issue":"1","key":"3826_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek J, Chan KE, Wong ZY, et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(1):20\u201330.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"3826_CR8","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1111\/liv.15024","volume":"41","author":"G Semmler","year":"2021","unstructured":"Semmler G, Datz C, Reiberger T, et al. Diet and exercise in NAFLD\/NASH: beyond the obvious. Liver Int. 2021;41(10):2249\u201368.","journal-title":"Liver Int"},{"issue":"1","key":"3826_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jhep.2016.08.023","volume":"66","author":"R Hashida","year":"2017","unstructured":"Hashida R, Kawaguchi T, Bekki M, et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review. J Hepatol. 2017;66(1):142\u201352.","journal-title":"J Hepatol."},{"issue":"10","key":"3826_CR10","doi-asserted-by":"publisher","first-page":"e31434","DOI":"10.5812\/hepatmon.31434","volume":"15","author":"A Shamsoddini","year":"2015","unstructured":"Shamsoddini A, Sobhani V, Ghamar Chehreh ME, et al. Effect of aerobic and resistance exercise training on liver enzymes and hepatic fat in Iranian men with nonalcoholic fatty liver disease. Hepat Mon. 2015;15(10):e31434.","journal-title":"Hepat Mon"},{"issue":"3","key":"3826_CR11","first-page":"195","volume":"26","author":"National Workshop on Fatty Liver and Alcoholic Liver Disease","year":"2018","unstructured":"National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association Fatty Liver Expert Committee, et al. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update. Zhonghua Gan Zang Bing Za Zhi. 2018;26(3):195\u2013203.","journal-title":"Zhonghua Gan Zang Bing Za Zhi."},{"issue":"3","key":"3826_CR12","doi-asserted-by":"publisher","first-page":"e00316","DOI":"10.14309\/ctg.0000000000000316","volume":"12","author":"P Charatcharoenwitthaya","year":"2021","unstructured":"Charatcharoenwitthaya P, Kuljiratitikal K, Aksornchanya O, et al. Moderate-intensity aerobic vs resistance exercise and dietary modification in patients with nonalcoholic fatty liver disease: a randomized clinical trial. Clin Transl Gastroenterol. 2021;12(3):e00316.","journal-title":"Clin Transl Gastroenterol"},{"issue":"11","key":"3826_CR13","first-page":"1313","volume":"24","author":"A de Piano","year":"2012","unstructured":"de Piano A, de Mello MT, Sanches Pde L, et al. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents. Eur J Gastroenterol Hepatol. 2012;24(11):1313\u201324.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"18","key":"3826_CR14","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1200\/JCO.22.01740","volume":"41","author":"JH Park","year":"2023","unstructured":"Park JH, Hong JY, Shen JJ, et al. Increased risk of young-onset digestive tract cancers among young adults age 20\u201339 years with nonalcoholic fatty liver disease: a nationwide cohort study. J Clin Oncol. 2023;41(18):3363\u201373.","journal-title":"J Clin Oncol"},{"key":"3826_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jare.2021.06.001","volume":"34","author":"S Wang","year":"2021","unstructured":"Wang S, Sheng F, Zou L, et al. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism. J Adv Res. 2021;34:109\u201322.","journal-title":"J Adv Res"},{"issue":"4","key":"3826_CR16","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1074\/jbc.M209525200","volume":"278","author":"G Lambert","year":"2003","unstructured":"Lambert G, Amar MJA, Guo G, et al. The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. J Biol Chem. 2003;278(4):2563\u201370.","journal-title":"J Biol Chem"},{"issue":"10","key":"3826_CR17","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","volume":"67","author":"N Jiao","year":"2018","unstructured":"Jiao N, Baker SS, Chapa-Rodriguez A, et al. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD. Gut. 2018;67(10):1881\u201391.","journal-title":"Gut"},{"issue":"5","key":"3826_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S2213-8587(22)00047-X","volume":"10","author":"H Jebeile","year":"2022","unstructured":"Jebeile H, Kelly AS, O\u2019Malley G, et al. Obesity in children and adolescents: epidemiology, causes, assessment, and management. Lancet Diabetes Endocrinol. 2022;10(5):351\u201365.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"3826_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-023-00435-4","volume":"9","author":"NB Lister","year":"2023","unstructured":"Lister NB, Baur LA, Felix JF, et al. Child and adolescent obesity. Nat Rev Dis Primers. 2023;9(1):24.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"3826_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11332-019-00544-2","volume":"15","author":"SM Tayebi","year":"2019","unstructured":"Tayebi SM, Saeidi A, Fashi M, et al. Plasma retinol-binding protein-4 and tumor necrosis factor-\u03b1 are reduced in postmenopausal women after combination of different intensities of circuit resistance training and Zataria supplementation. Sport Sci Health. 2019;15(3):551\u20138.","journal-title":"Sport Sci Health"},{"issue":"4","key":"3826_CR21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1055\/a-1560-5401","volume":"43","author":"S Atashak","year":"2022","unstructured":"Atashak S, Stannard SR, Daraei A, et al. High-intensity interval training improves Lipocalin-2 and Omentin-1 levels in men with obesity. Int J Sports Med. 2022;43(4):328\u201335.","journal-title":"Int J Sports Med"},{"key":"3826_CR22","doi-asserted-by":"publisher","first-page":"895512","DOI":"10.3389\/fendo.2022.895512","volume":"13","author":"A Ataeinosrat","year":"2022","unstructured":"Ataeinosrat A, Saeidi A, Abednatanzi H, et al. Intensity dependent effects of interval resistance training on myokines and cardiovascular risk factors in males with obesity. Front Endocrinol (Lausanne). 2022;13:895512.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3826_CR23","doi-asserted-by":"publisher","first-page":"797574","DOI":"10.3389\/fphys.2021.797574","volume":"12","author":"A Saeidi","year":"2022","unstructured":"Saeidi A, Shishvan SR, Soltani M, et al. Differential effects of exercise programs on neuregulin 4, body composition and cardiometabolic risk factors in men with obesity. Front Physiol. 2022;12:797574.","journal-title":"Front Physiol"},{"key":"3826_CR24","doi-asserted-by":"publisher","first-page":"807110","DOI":"10.3389\/fphys.2021.807110","volume":"12","author":"H Zouhal","year":"2022","unstructured":"Zouhal H, Berro AJ, Kazwini S, et al. Effects of exercise training on bone health parameters in individuals with obesity: a systematic review and meta-analysis. Front Physiol. 2022;12:807110.","journal-title":"Front Physiol"},{"key":"3826_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.atherosclerosis.2018.05.002","volume":"274","author":"MA Wewege","year":"2018","unstructured":"Wewege MA, Thom JM, Rye KA, et al. Aerobic, resistance or combined training: a systematic review and meta-analysis of exercise to reduce cardiovascular risk in adults with metabolic syndrome. Atherosclerosis. 2018;274:162\u201371.","journal-title":"Atherosclerosis"},{"issue":"4","key":"3826_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/hep4.1490","volume":"4","author":"SY Kwan","year":"2020","unstructured":"Kwan SY, Jiao J, Qi J, et al. Bile acid changes associated with liver fibrosis and steatosis in the Mexican-American population of South Texas. Hepatol Commun. 2020;4(4):555\u201368.","journal-title":"Hepatol Commun"},{"issue":"1","key":"3826_CR27","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41598-023-28647-4","volume":"13","author":"S Marchian\u00f2","year":"2023","unstructured":"Marchian\u00f2 S, Biagioli M, Morretta E, et al. Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH. Sci Rep. 2023;13(1):1602.","journal-title":"Sci Rep"},{"issue":"12","key":"3826_CR28","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3390\/ph15121516","volume":"15","author":"SH Elhini","year":"2022","unstructured":"Elhini SH, Wahsh EA, Elberry AA, et al. The impact of an SGLT2 inhibitor versus ursodeoxycholic acid on liver steatosis in diabetic patients. Pharmaceuticals (Basel). 2022;15(12):1516.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3826_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2147\/HMER.S188991","volume":"11","author":"S Ganguli","year":"2019","unstructured":"Ganguli S, DeLeeuw P, Satapathy SK. A review of current and upcoming treatment modalities in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Hepat Med. 2019;11:159\u201378.","journal-title":"Hepat Med"},{"issue":"5","key":"3826_CR30","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jhep.2023.07.034","volume":"79","author":"L Adorini","year":"2023","unstructured":"Adorini L, Trauner M. FXR agonists in NASH treatment. J Hepatol. 2023;79(5):1317\u201331.","journal-title":"J Hepatol"},{"issue":"1","key":"3826_CR31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","volume":"71","author":"M Trauner","year":"2022","unstructured":"Trauner M, Fuchs CD. Novel therapeutic targets for cholestatic and fatty liver disease. Gut. 2022;71(1):194\u2013209.","journal-title":"Gut"},{"issue":"12","key":"3826_CR32","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.3390\/cells10123306","volume":"10","author":"W Zhu","year":"2021","unstructured":"Zhu W, Sahar NE, Javaid HMA, et al. Exercise-induced Irisin decreases inflammation and improves NAFLD by competitive binding with MD2. Cells. 2021;10(12):3306.","journal-title":"Cells"},{"issue":"7","key":"3826_CR33","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1080\/17461391.2019.1571114","volume":"19","author":"P Farzanegi","year":"2019","unstructured":"Farzanegi P, Dana A, Ebrahimpoor Z, et al. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): roles of oxidative stress and inflammation. Eur J Sport Sci. 2019;19(7):994\u20131003.","journal-title":"Eur J Sport Sci"},{"key":"3826_CR34","doi-asserted-by":"publisher","first-page":"623852","DOI":"10.3389\/fcell.2021.623852","volume":"9","author":"EM Pioltine","year":"2021","unstructured":"Pioltine EM, Costa CB, Barbosa Latorraca L, et al. Treatment of in vitro-matured bovine oocytes with tauroursodeoxycholic acid modulates the oxidative stress signaling pathway. Front Cell Dev Biol. 2021;9:623852.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"3826_CR35","first-page":"149","volume":"11","author":"Y Tanabe","year":"1989","unstructured":"Tanabe Y, Urata H, Kiyonaga A, et al. Changes in serum concentrations of taurine and other amino acids in clinical antihypertensive exercise therapy. Clin Exp Hypertens A. 1989;11(1):149\u201365.","journal-title":"Clin Exp Hypertens A"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03826-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03826-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03826-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T06:45:05Z","timestamp":1744267505000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03826-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3826"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03826-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Consent for publication was obtained from all participants whose identifying information is included in the manuscript. The study was approved by the Medical Ethics Committee of Xuzhou Medical University (Approval number: XZMU-2022-ZK068).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from all participants whose identifying information is included in the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"239"}}